Better Money Decisions’s Zimmer Biomet ZBH Stock Holding History

Better Money Decisions’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-71	Closed	-$7K	–	468
2022 Q2	$7K	Buy	+71	New	+$8.42K	0.01%	356
2021 Q4	–	Sell	-73	Closed	-$10K	–	602
2021 Q3	$10K	Hold	73	–	–	0.01%	403
2021 Q2	$11K	Hold	73	–	–	0.01%	375
2021 Q1	$11K	Buy	+73	New	+$11.3K	0.01%	330

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Better Money Decisions's ZBH Position: Q3 2022 in Review

Better Money Decisions sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 71 shares — an estimated $7K sold.

Better Money Decisions first reported a position in ZBH in Q1 2021 and held it in 4 quarters. The position peaked at $11K in Q2 2021. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Better Money Decisions reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
Better Money Decisions sold 71 Zimmer Biomet shares in Q3 2022, an estimated $7K.
Better Money Decisions first reported a position in Zimmer Biomet in Q1 2021 and held it in 4 quarters.
Better Money Decisions's Zimmer Biomet position peaked at $11K in Q2 2021.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Better Money Decisions's 13F filing for Q3 2022, filed 28 Oct 2022.